Kalyagen Newsroom - Profile and News Archive
Kalyagen™ was founded by Christian Drapeau, author of the bestseller Cracking the Stem Cell Code. Kalyagen is a leader in the research and development of natural products aimed at supporting stem cell function of the body. Stem cells constitute the natural repair system of the body, and stem cell enhancers have been documented to strongly contribute to improving health and quality of life.
STEMREGEN® is the first stem cell enhancer product developed by Kalyagen™. STEMREGEN is a unique blend of proprietary plant-based extracts documented to support Endogenous Stem Cell Mobilization and provide other health benefits.
Media Contact:
Biomics, LLC (dba Kalyagen™)
Herbert Dogan
Chief Marketing Officer
(310-433-8072)
hgd@kalyagen.com
Engage with Kalyagen
Learn more online at: https://www.kalyagen.com/
Follow: 𝕏 (Twitter) | Facebook | Instagram | YouTube
Press Releases from Kalyagen :
Kalyagen Announces Attendance at the Fort Lauderdale Open with PGA Associate Jerrel Gill
AUSTIN, Texas, April 29, 2022 (SEND2PRESS NEWSWIRE) — Kalyagen® is pleased to announce that it will be attending the Fort Lauderdale Open as part of its sponsorship of golf professional Jerrel Gill. The Open will be hosted at the Fort Lauderdale Country Club on May 2-3, 2022.
Kalyagen Announces Attendance at Paleo f(x) 2022 Conference
AUSTIN, Texas, April 27, 2022 (SEND2PRESS NEWSWIRE) — Kalyagen is pleased to announce that it will be attending and hosting a booth (#121) at the upcoming Paleo f(x)™ 2022 conference to be held in Austin on April 29 – May 1. STEMREGEN® is a unique and patent-pending blend of proprietary plant-based extracts documented to increase the number of circulating stem cells by stimulating Endogenous Stem Cell Mobilization (ESCM).
Kalyagen Announces Supporting Partnership of Two South Florida PGA Events and PGA Associate Jerrel Gill
AUSTIN, Texas, March 10, 2022 (SEND2PRESS NEWSWIRE) — Kalyagen® is pleased to announce that it is a supporting partner of two upcoming South Florida PGA Section events and golf professional Jerrel Gill. The two events are the South Florida PGA Foundation PGA HOPE Classic on May 12, 2022 and the South Florida Open on June 21-23, 2022.
Kalyagen Announces Attendance at 2022 SXSW Wellness Expo
AUSTIN, Texas, March 4, 2022 (SEND2PRESS NEWSWIRE) — Kalyagen is pleased to announce that it will be attending and hosting a booth (#215) at the upcoming South by Southwest® (SXSW®) Wellness Expo. The Wellness Expo is open to all SXSW Badges and is free and open to the public from March 12-13, 2022 from 11 a.m. – 5 p.m. at the Palmer Events Center in Exhibit Halls 1 & 2.
Kalyagen™ Announces Registration of STEMREGEN® in Spain, CEO at Madrid Stem Cell Symposium
AUSTIN, Texas, Oct. 12, 2021 (SEND2PRESS NEWSWIRE) — Kalyagen is pleased to announce the successful product registration of STEMREGEN® in Spain. This announcement coincides with Christian Drapeau’s, CEO and Chief Scientist of Kalyagen, trip to Madrid, Spain last week to speak at the IV Jornadas Internacionales Otto H. Warburg symposium at the NH Madrid Príncipe de Vergara.
Kalyagen Announces Release of Free eBook on How to Optimize Health Using Stem Cells
AUSTIN, Texas, July 14, 2021 (SEND2PRESS NEWSWIRE) — Kalyagen® has announced the release and availability of a free eBook, “The Stemregen Effect – Tapping into the Power of Your Own Stem Cells,” which provides an overview of how stem cells are the body’s repair system and how STEMREGEN®, a natural stem cell enhancer, has been documented to increase the number of circulating stem cells by stimulating Endogenous Stem Cell Mobilization (ESCM).
Kalyagen and Uniwell Announce Partnership to Manufacture Proprietary and Third-Party Skin Care Products
AUSTIN and FORT WORTH, Texas, June 15, 2021 (SEND2PRESS NEWSWIRE) — Kalyagen® and Uniwell Laboratories announced today that they have entered into a joint venture to produce the unique, patent-pending Juviqa Stem Cell Beauty System and expand Uniwell’s manufacturing capabilities to include cosmetics.
Kalyagen and Intelicure Announce Partnership to Distribute STEMREGEN in Canada
AUSTIN, Texas and VANCOUVER, B.C., June 4, 2021 (SEND2PRESS NEWSWIRE) — Kalyagen® and Intelicure Health Inc. announced today that they have entered into an agreement to promote and distribute throughout Canada STEMREGEN®, a natural stem cell enhancer documented to increase the number of circulating stem cells by stimulating Endogenous Stem Cell Mobilization (ESCM).
Kalyagen Announces Next ‘The Stemregen Effect’ Commercial Featuring Chris Spencer to be Filmed in Belize
AUSTIN, Texas, May 13, 2021 (SEND2PRESS NEWSWIRE) — Kalyagen™ is pleased to announce that the next part of “The Stemregen Effect” digital media campaign will be filmed in Belize and feature actor, comedian, writer and producer Chris Spencer to promote STEMREGEN®, a natural stem cell enhancer documented to increase the number of circulating stem cells by stimulating Endogenous Stem Cell Mobilization (ESCM).
Kalyagen Announces Release of ‘The Stemregen Effect’ Commercial with Three Former UCLA Players to Coincide with the Bruins Advancing to the Final Four
AUSTIN, Texas, April 3, 2021 (SEND2PRESS NEWSWIRE) — Kalyagen™ is pleased to announce the release of its “The Stemregen Effect” social media ad featuring former UCLA Bruins and NBA players Niguel Miguel, Marques Johnson and Mitchell Butler to promote STEMREGEN®, a natural stem cell enhancer documented to increase the number of circulating stem cells by stimulating Endogenous Stem Cell Mobilization (ESCM).
Kalyagen Announces Launch of ‘Stem the Tide of Time’ Campaign Featuring NBA Hall of Fame Finalist Marques Johnson
AUSTIN, Texas, Feb. 8, 2021 (SEND2PRESS NEWSWIRE) — Kalyagen is pleased to announce the launch of its “Stem the Tide of Time” social media campaign featuring former UCLA Bruin and Milwaukee Buck All-Star Marques Johnson to promote STEMREGEN;, a natural stem cell enhancer documented to increase the number of circulating stem cells by stimulating Endogenous Stem Cell Mobilization (ESCM). (VIDEO)
Kalyagen™ Announces Launch of Clinical Trial to Evaluate STEMREGEN® and Stem Cells for Advanced Heart Failure Patients
AUSTIN, Texas, Feb. 5, 2021 (SEND2PRESS NEWSWIRE) — Kalyagen™, along with the Sociedad Espanola de Medicina Regenerativa y Terapia Celular (the “Spanish Society of Regenerative Medicine and Cell Therapy”), is pleased to announce the launch of a multicenter clinical trial, “The Effect of Stemregen and Adipose Stroma Vascular Fraction (SVF) Either Individually or in Combination in Patient With Heart Failure,” to evaluate the use of stem cell therapies in patients suffering from heart failure.